Vaxchora (cholera vaccine, oral, live)
- Region
- 🇪🇺 EU
- Active substance
- cholera vaccine, oral, live
- Company
- Bavarian Nordic A/S
- Status
- Authorised
- Therapeutic area
- Cholera
- CHMP opinion
- Thu 30 Jan 2020
- EU approval
- Wed 01 Apr 2020
- Application
- EMEA/H/C/003876
- ATC
- J07AE02
- Official record
- www.ema.europa.eu
Indication
Vaxchora is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older. This vaccine should be used in accordance with official recommendations.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Dukoral Authorised · Valneva Sweden AB
Follow Vaxchora
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.